| Jenna L Deleon, LMLP | |
|
3000 Broadway Ave, Hays, KS 67601-1916 | |
| (785) 628-3111 | |
| Not Available |
| Full Name | Jenna L Deleon |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 3000 Broadway Ave, Hays, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649753278 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 2869 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jenna L Deleon, LMLP 3000 Broadway Ave, Hays, KS 67601-1916 Ph: () - | Jenna L Deleon, LMLP 3000 Broadway Ave, Hays, KS 67601-1916 Ph: (785) 628-3111 |
News Archive
Angiotech Pharmaceuticals, Inc. has announced that it has elected to suspend enrolment in its U.S. and EU human clinical trials for its Vascular Wrap product candidate in patients undergoing surgery for hemodialysis access, pending a safety review to evaluate an imbalance of infections that have been observed between the two study groups.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Occupational exposure to fluid commonly used in metal machining operations may be related to a rare, irreversible lung disease, according to research presented at the European Respiratory Society's (ERS) International Congress today (28 September, 2015).
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
› Verified 8 days ago
Brandie Bieker, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1010 Downing Ave Ste 60, Hays, KS 67601 Phone: 785-621-4417 | |
Mr. Walter B Hill, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 East 7th St, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-1438 | |
Mr. Paul Peter Karlin, LMLP LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-1248 | |
Eric R Brown, T-LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 323 West 12th Street, Hays, KS 67601 Phone: 785-623-2416 Fax: 785-623-2418 | |
Clayton W. Howard, T-LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th St, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-0330 | |
Mr. David Scott Anderson, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-1438 | |
Ms. Catharine I Shaffer, MS LMLP LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th St, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-0330 |